Explore more publications!

Africa News Guide: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Africa News Guide.

Press releases published on April 20, 2026

Winners Announced at the 42nd Annual L. Ron Hubbard Writers and Illustrators of the Future Awards Gala
Pan-African Gaming Taxation & Revenue Summit (PAGTR) 2026
QianFa Fine Chemical: A Trusted China Leading Dibenzoyl Peroxide Manufacturer with Global Reach and ISO Certification
FMUSER Releases Multi-Language Video Guide for Hotel IPTV Solutions
Cronus Capital Announces 10% Equity Distribution Challenge: Teases New Reality Series
Morocco Strategic Minerals Announces Proposed Private Placement
Corporation de minéraux stratégiques du Maroc annonce un placement privé proposé
BVI Announces CE Mark Under EU MDR for Virtuoso®, A Brand New Dual-Function Surgical Platform
HINWEIS ZUM NICHTBEACHTEN -- BVI Medical, Inc.
AVIS À IGNORER -- BVI Medical, Inc.
Morocco Strategic Minerals Corp. Announces District-Scale Option Agreement in Morocco's Western High Atlas
NevGold Announces C$25M Brokered Private Placement Financing
Avicanna Announces Agenda for 6th Annual Clinical Symposium on Cannabinoid Therapeutics
Allogene Therapeutics Showcases Momentum with Clinical and Platform Advancements in Allogeneic CAR T at AACR 2026
Tanbreez Mining Greenland A/S Appoints Thomas “TYT” Mogensen as Chief Executive Officer
Amneal Announces Additional Positive Interim Phase 4 ELEVATE-PD Results with CREXONT® for Parkinson’s Disease, Including Over 3 More Hours of Daily “Good On” Time When Switching from RYTARY®
Fulcrum Therapeutics to Host First Quarter 2026 Financial Results Conference Call and Webcast on Monday, April 27, 2026, at 8:00 a.m. ET
Global Uranium Completes Phase 1 Earn-In at Astro Project and Secures Initial 20% Interest
COSCIENS Biopharma Inc. Provides Update on its Plan to Suspend U.S. Public Company Reporting Obligations
Atsena Therapeutics Receives Data Monitoring Committee Recommendation to Proceed with Pivotal Part C Cohort of Phase 1/2/3 LIGHTHOUSE Trial Evaluating ATSN-201 in Patients with X-linked Retinoschisis

Share us

on your social networks:
AGPs

Get the latest news on this topic.

SIGN UP FOR FREE TODAY

No Thanks

By signing to this email alert, you
agree to our Terms & Conditions